FindTrial
Sign In

Effects of 10-Hz repetitive transcranial magnetic therapy (rTMS) on clinical symptoms and cognitive function in schizophrenic patients with auditory hallucinations

A randomized double-blind controlled trial of repeated transcranial magnetic resonance (rTMS) therapy in schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056801
Enrollment
Unknown
Registered
2022-02-17
Start date
2018-12-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Experimental group:Real stimulation
Control group:Sham stimulation

Sponsors

Kangning Hospital Affiliated to Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Right-handed; 2. The han nationality; 3. Aged between 18 and 60; 4. Auditory Hallucination Rating Scale (AHRS)>10; 5. Take a stable dose of antipsychotics for at least 1 month before entering the study.

Exclusion criteria

Exclusion criteria: 1. Any major physical diseases (such as cardiovascular, liver, kidney, gastrointestinal diseases, etc.); 2. A history of pacemaker, intracranial metal, or previous epilepsy or head injury; 3. Pregnant or lactating patients; 4. Electroconvulsive therapy (ECT) or modified ECT (MECT) in the last 3 months; 5. Not receiving any psychological treatment; 6. A history of alcohol or other substance abuse or dependence.

Design outcomes

Primary

MeasureTime frame
Reproducible sheath neuropsychological state measurement;Positive and negative symptom scales;Auditory hallucination rating scale;—

Countries

China

Contacts

Public ContactFan Kaili
fkl669988@163.com+86 13587551282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026